In vitro evaluation of 99mTc-sultamicillin for infection imaging
Authors:
- 1 June 2021
- journal article
- research article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 42 (6) , 285-293
Abstract
Early detection of the site of infection non-invasively with radiolabeled molecules is important for the success of treatment. Technetium-99m labeled antibiotics have the potential to discriminate between bacterial infection and sterile inflammation. Sultamicillin is the tosylate salt of the double ester of sulbactam plus ampicillin. In this study, sultamicillin was labeled with Tc-99m according to the stannous chloride method. Quality control studies of radiolabeled sultamicillin were performed by radiochromatographic methods. In vitro binding assays were performed in live and heat-killed gram-positive Staphylococcus aureus and gram-negative Escherichia coli strains. The radiolabeling yield of Tc-99m-sultamicillin was determined as 97.8% +/- 3.1% (n = 5). The maximum bacterial uptake of Tc-99m-sultamicillin was 80.7% +/- 11.00% at 4 h for living S. aureus and 93.2% +/- 4.40% at 2 h for E. coli. Bacterial uptake study results show that sultamicillin has the potential to be a nuclear imaging agent, especially in infections caused by gram-negative E. coli and gram-positive S. aureus.Keywords
Funding Information
- Ege University (17 NBE 007)
This publication has 38 references indexed in Scilit:
- Radiosynthesis and biodistribution of 99mTc-rifampicin: A novel radiotracer for in-vivo infection imagingApplied Radiation and Isotopes, 2010
- The Bacterial Cell EnvelopeCold Spring Harbor Perspectives in Biology, 2010
- The clinical consequences of antimicrobial resistanceCurrent Opinion in Microbiology, 2009
- Preparation, quality control and stability of 99mTc‐sparafloxacin complex, a novel agent for detecting sites of infectionJournal of Labelled Compounds and Radiopharmaceuticals, 2009
- Clinically Proven Radiopharmaceuticals for Infection Imaging: Mechanisms and ApplicationsSeminars in Nuclear Medicine, 2009
- Rational antibiotic therapy and the position of ampicillin/sulbactamInternational Journal of Antimicrobial Agents, 2008
- Can we produce an image of bacteria with radiopharmaceuticals?European Journal of Nuclear Medicine and Molecular Imaging, 2008
- Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in EuropeClinical Microbiology and Infection, 2008
- Ampicillin/SulbactamDrugs, 2007
- Infection imaging with radiopharmaceuticals in the 21st centuryBrazilian Archives of Biology and Technology, 2002